Literature DB >> 19358272

Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions.

Juliette Desfrançois1, Laurent Derré, Murielle Corvaisier, Bernard Le Mével, Véronique Catros, Francine Jotereau, Nadine Gervois.   

Abstract

Breast cancer remains a leading cause of cancer-related death within the female population. Immunotherapy is expected to provide additional therapeutic benefits but has met so far limited success. This may be due in part to the poor understanding of immune responses to breast cancer. Although CD4(+) and CD8(+) T lymphocytes infiltrate these tumors, the phenotype and functions of these cells remain ill defined. This study was designed to investigate further about these questions, taking advantage of multiparameter flow cytometry on lymphocytes derived from peripheral blood, solid tumors, metastatic lymph nodes and pleural effusions samples of patients with breast cancer. Results showed that, in addition to conventional CD4(+) and CD8(+) alphabeta T cells, individual tumors and most pleural effusions contained significant fractions of unconventional double positive (DP) CD4(+)CD8(+) alphabeta T cells. These DP T cells displayed the phenotype and cytotoxic potential of effector/memory activated CD8(+) T cells but differed essentially from these cells by a high production of IL-5 and IL-13. The increased frequency of DP T cells in advanced breast cancer and their high lytic potential and original cytokine profile suggest that this T-cell subset may play a specific role in the regulation of immune responses to human breast cancer. Copyright 2009 UICC.

Entities:  

Mesh:

Year:  2009        PMID: 19358272     DOI: 10.1002/ijc.24366

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Different cytokine profiles of skin-derived T cell cultures from patients with atopic dermatitis and psoriasis.

Authors:  Britta C Martel; Beatrice Dyring-Andersen; Lone Skov; Kristian Thestrup-Pedersen; Søren Skov; Kresten Skak; Lars K Poulsen
Journal:  Inflamm Res       Date:  2015-12-31       Impact factor: 4.575

Review 2.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

3.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

4.  Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C.

Authors:  Michelina Nascimbeni; Stanislas Pol; Bertrand Saunier
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

5.  CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells.

Authors:  Tiphaine Parrot; Romain Oger; Houssem Benlalam; Diane Raingeard de la Blétière; Nicolas Jouand; Anne Coutolleau; Laurence Preisser; Amir Khammari; Brigitte Dréno; Philippe Guardiola; Yves Delneste; Nathalie Labarrière; Nadine Gervois
Journal:  Oncoimmunology       Date:  2016-10-28       Impact factor: 8.110

6.  Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15.

Authors:  Marie-Laure Clénet; François Gagnon; Ana Carmena Moratalla; Emilie C Viel; Nathalie Arbour
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

7.  Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.

Authors:  Laurence C Menard; Paul Fischer; Bijal Kakrecha; Peter S Linsley; Erik Wambre; Maochang C Liu; Blake J Rust; Deborah Lee; Becky Penhallow; Nataly Manjarrez Orduno; Steven G Nadler
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

8.  Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.

Authors:  Juliette Desfrançois; Agnès Moreau-Aubry; Virginie Vignard; Yann Godet; Amir Khammari; Brigitte Dréno; Francine Jotereau; Nadine Gervois
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

9.  In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.

Authors:  Luc Van Kaer; Whitney A S Rabacal; Holly M Scott Algood; Vrajesh V Parekh; Danyvid Olivares-Villagómez
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

10.  Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus.

Authors:  Yongkang Wu; Bei Cai; Weihua Feng; Bin Yang; Zhuochun Huang; Chuan Zuo; Lanlan Wang
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.